Stockreport

ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference [Financial Post (Toronto, Ontario, Canada)]

ProMIS Neurosciences Inc.  (PMN) 
PDF biotechnology company focused on the generation and development of therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, today announced that Ne [Read more]